Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 4, 2003

View Archived Issues

BMS researchers describe new metalloproteinase inhibitors and their use

AxyS and Cytovia patent novel caspase activators for use as antitumor agents

New 5-HT1A antagonist/5-HT reuptake inhibitor identified at GSK

New inhibitors of ERK2 and other protein kinases covered by Vertex patent

Merck identifies estrogen ERalpha modulators useful in osteoporosis, cancer, etc.

Wyeth scientists claim novel estrogen receptor modulators

Imidazoline antidiabetic agent NNC-77-0020 modulates pancreatic hormone secretion

Novel phospholipid derivative of indomethacin shows potential in Alzheimer's disease Rx

SBIR grant aids search for longer acting adenosine A2A agonists

Approvable letter for Orthovisc

German approval for Leuprogel one-month depot product

Faulding changes name to Mayne Pharma

Rolling NDA submission continues for Onco TCS

Enhanced antiinflammatory effects of NO-releasing statins reported by NicOx

Inologic makes good progress in INO-4995 development

Positive results for icatibant in treatment of refractory ascites in liver cirrhosis

La Jolla discovers inhibitors of SSAO

Maxim licenses MX-90745 series to Myriad

Doripenem active in vitro against P. aeruginosa and B. cepacia

Peptech and Biosceptre enter joint venture agreement

Xcytrin granted fast track status for brain metastases in NSCLC patients

RVT 202 study of Reverset completes enrollment

Sepracor reports phase III program results for Xopenex HFA MDI

Skyepharma and Novartis to develop new COPD and asthma treatment

Stressgen and Roche restructure HspE7 alliance

Telcyta awarded fast track status for third-line therapy of NSCLC

Noncalcemic vitamin D analogue potently suppresses PTH in renal failure

In vivo efficacy of drugs targeting tumor vasculature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...